Overview

A Comparison of Three Fluoroquinolone Topical Eyedrops in the Treatment of Infectious Corneal Ulcers.

Status:
Terminated

Trial end date:
2014-05-01

Target enrollment:

Participant gender:

Summary

This Phase II study will evaluate the safety and efficacy of three fluoroquinolone ophthalmic agents to determine the optimal treatment in patients with infectious corneal ulcers.

Phase:

Phase 2

Details

Lead Sponsor:

Cornea Consultants Of Nashville

Collaborators:

Bausch & Lomb Incorporated
SCRI Development Innovations, LLC

Treatments:

7-(3-aminohexahydro-1H-azepin-1-yl)-8-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid
Besifloxacin
Fluoroquinolones
Gatifloxacin
Moxifloxacin
Norgestimate, ethinyl estradiol drug combination
Ophthalmic Solutions
Pharmaceutical Solutions